UBR1 Antibody (2F5)

This product is produced by and distributed for Abnova, a company based in Taiwan.

The N-end rule pathway is one proteolytic pathway of the ubiquitin system. The recognition component of this pathway, encoded by this gene, binds to a destabilizing N-terminal residue of a substrate protein and participates in the formation of a substrate-linked multiubiquitin chain. This leads to the eventual degradation of the substrate protein. The protein described in this record has a RING-type zinc finger and a UBR-type zinc finger. Mutations in this gene have been associated with Johanson-Blizzard syndrome.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 2 of 2.

Publications using H00197131-M01	Applications	Species
Xu Z, Peng AW, Oshima K et al. MAGI-1, A Cidate Stereociliary Scaffolding Protein, Associates with the Tip-Link Component Cadherin 23. J Neurosci;28(44):11269-11276. 2008-01-01 [PMID: 18971469]
Ozawa Y, Nakao K, Kurihara T et al. Roles of STAT3/SOCS3 pathway in regulation of the visual function and ubiquitin proteasome-dependent degradation of Rhodopsin during retinal inflammation. J Biol Chem. 2008-07-09 [PMID: 18614536]

Array H00197131-M01

• UBR1 Antibodies
• UBR1 Lysate
• UBR1 Proteins